D
Dragana Nikolic
Researcher at University of Palermo
Publications - 98
Citations - 3725
Dragana Nikolic is an academic researcher from University of Palermo. The author has contributed to research in topics: Type 2 diabetes & Dyslipidemia. The author has an hindex of 30, co-authored 87 publications receiving 2867 citations. Previous affiliations of Dragana Nikolic include University of Catania & University of Belgrade.
Papers
More filters
Journal ArticleDOI
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.
Journal ArticleDOI
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
Pablo Perez-Martinez,Dimitri P. Mikhailidis,Vasilios G. Athyros,Mònica Bulló,Patrick Couture,María Isabel Covas,María Isabel Covas,Lawrence de Koning,Javier Delgado-Lista,Andrés Díaz-López,Christian A. Drevon,Ramon Estruch,Katherine Esposito,Montserrat Fitó,Montserrat Fitó,Marta Garaulet,Dario Giugliano,Antonio Garcia-Rios,Niki Katsiki,Genovefa Kolovou,Benoît Lamarche,Maria Ida Maiorino,Guillermo Mena-Sánchez,Araceli Muñoz-Garach,Dragana Nikolic,Jose M. Ordovas,Jose M. Ordovas,Jose M. Ordovas,Francisco Pérez-Jiménez,Manfredi Rizzo,Jordi Salas-Salvadó,Helmut Schröder,Francisco J. Tinahones,Rafael de la Torre,Rafael de la Torre,Ben van Ommen,Suzan Wopereis,Emilio Ros,Emilio Ros,Jose Lopez-Miranda +39 more
TL;DR: A healthy lifestyle is critical to prevent or delay the onset of MetS in susceptible individuals and to prevent cardiovascular disease and type 2 diabetes in those with existing MetS.
Journal ArticleDOI
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel
Maciej Banach,Manfredi Rizzo,Peter P. Toth,Michel Farnier,Michael H. Davidson,Khalid Al-Rasadi,Wilbert S. Aronow,Vasilis G. Athyros,Dragan M. Djuric,Marat V. Ezhov,Robert S. Greenfield,G. Kees Hovingh,Karam Kostner,Corina Serban,Daniel Lighezan,Zlatko Fras,Patrick M. Moriarty,Paul Muntner,Assen Goudev,Richard Ceska,Stephen J. Nicholls,Marlena Broncel,Dragana Nikolic,Daniel Pella,Raman Puri,Jacek Rysz,Nathan D. Wong,Laszlo Bajnok,Steven R. Jones,Kausik K. Ray,Dimitri P. Mikhailidis +30 more
TL;DR: The aim of this position paper was to suggest a unified definition of statin intolerance, and to complement the recent EAS statement on SAMS, where the pathophysiology, diagnosis and the management were comprehensively presented.
Journal ArticleDOI
The Role of Nutraceuticals in Statin Intolerant Patients
Maciej Banach,Angelo Maria Patti,Rosaria Vincenza Giglio,Arrigo F G Cicero,Atanas G. Atanasov,Atanas G. Atanasov,Gani Bajraktari,Eric Bruckert,Olivier S. Descamps,Dragan M. Djuric,Marat V. Ezhov,Zlatko Fras,Stephan von Haehling,Niki Katsiki,Michel Langlois,Gustavs Latkovskis,G.B. John Mancini,Dimitri P. Mikhailidis,Olena Mitchenko,Patrick M. Moriarty,Paul Muntner,Dragana Nikolic,Demosthenes B. Panagiotakos,György Paragh,Bernhard Paulweber,Daniel Pella,Christos Pitsavos,Željko Reiner,Giuseppe M.C. Rosano,Robert S. Rosenson,Jacek Rysz,Amirhossein Sahebkar,Maria-Corina Serban,Dragos Vinereanu,Michal Vrablík,Gerald F. Watts,Nathan D. Wong,Manfredi Rizzo +37 more
TL;DR: The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
Journal ArticleDOI
Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches
Dragana Nikolic,Niki Katsiki,Giuseppe Montalto,Esma R. Isenovic,Dimitri P. Mikhailidis,Manfredi Rizzo +5 more
TL;DR: The clinical significance of sdLDL in being overweight and obesity, as well as the efficacy of anti-obesity drugs on LDL subfractions in these individuals are reviewed; a short comment on HDL subclasses is also included.